Key Players and Competitive Dynamics in the Leukapheresis Market

The leukapheresis industry is on a strong growth trajectory as advancements in cell-based therapies and personalized medicine continue to gain momentum. Innovations in technology and increasing investments in immunology research are also playing a significant role in shaping this expanding market. Let's explore the market size projections, leading players, emerging trends, and key segments defining the leukapheresis landscape.

Leukapheresis Market Size Outlook Through 2030
The leukapheresis market is projected to reach an impressive $104.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This expansion is driven by multiple factors such as the rapid development of CAR-T and other cell-based therapies, increased funding in immunology research, growing demand for tailored medical treatments, the scaling up of biopharmaceutical manufacturing, and technological progress in automation for apheresis procedures. Notable trends in this period include a heightened use of leukapheresis for cell and gene therapy applications, rising demand for immune cell collection particularly in oncology, greater implementation of automated leukapheresis systems, expansion in clinical research involving leukapheresis, and a stronger focus on patient-friendly disposable apheresis kits.

Download a free sample of the leukapheresis market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Drivers Behind Growth in the Leukapheresis Market
The surge in cell and gene therapy development is a major catalyst boosting the leukapheresis market. As therapies become more personalized and complex, collecting high-quality immune cells efficiently and safely is critical, which increases reliance on advanced leukapheresis technologies.
Additionally, ongoing innovations in automated apheresis systems are making procedures faster and more reliable. These advancements help reduce risks for patients while improving the quality and consistency of collected cells, which is essential for the success of advanced therapeutic products.

Top Companies Defining the Leukapheresis Industry
The leukapheresis sector features several influential players shaping its growth and innovation landscape. Leading companies include Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, and Cellsep Laboratories. These organizations are advancing technologies, expanding manufacturing capabilities, and driving clinical adoption of leukapheresis.

View the full leukapheresis market report:
https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Collaborations Highlighting Industry Progress
A notable partnership formed in July 2023, between Czech-based contract manufacturer SCTbio and Austria's Cyto-care.eu GmbH, aims to refine the cryopreservation process for cell therapies across Europe. Their collaboration focuses on improving the collection, freezing, quality control, and logistics of leukapheresis materials - crucial steps in producing advanced therapy medicinal products (ATMPs). Cyto-care.eu specializes in providing cell products to support biomedical research, drug development, and cell and gene therapy, reinforcing the importance of reliable leukapheresis workflows.

Emerging Trends Steering the Leukapheresis Market
One of the prominent trends is the development of GMP-grade leukopaks, which are leukapheresis products manufactured under strict good manufacturing practice (GMP) standards. These products ensure high viability and functionality of immune cells, which are vital for efficient cell therapy manufacturing.
For example, in November 2024, US biotechnology firm Sanguine Biosciences introduced LeukoCer, a GMP-grade leukopak designed to optimize workflows and speed up cell therapy R&D. LeukoCer provides fresh or half packs produced with rigorous quality control, enabling researchers to accelerate bringing new therapies to patients.

Detailed Segmentation of the Global Leukapheresis Market
The report breaks down the leukapheresis market into several important categories.
By apheresis type, it includes granulocyte apheresis, lymphocyte apheresis, and monocyte apheresis.
In terms of products, the market covers leukapheresis devices, centrifugal devices, membrane separators, and disposable leukapheresis kits.
Applications span research, cancer research, immunology research, therapeutic uses, hematologic disorders, autoimmune diseases, and other areas.
End users include blood component providers and blood centers, academic and research institutions, pharmaceutical and biotech companies, as well as hospitals and transfusion centers.

Further subsegments dive deeper into specific cell types, such as neutrophil, eosinophil, and basophil apheresis within the granulocyte category; T-cell, B-cell, and natural killer (NK) cell apheresis for lymphocytes; and classical, non-classical, and intermediate monocyte apheresis. This detailed classification helps provide clarity on the diverse applications and specialized approaches within the leukapheresis field.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.